Cr. Riedl et al., Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: Introduction of a new test, J UROL, 164(6), 2000, pp. 2108-2111
Purpose: It is often difficult to determine the functional status of the de
trusor muscle in patients with detrusor areflexia. We performed a clinical
study to establish a test defining residual detrusor capacity in such patie
nts.
Materials and Methods: In phase 1, 5 controls with detrusor areflexia were
tested with an intravesical instillation of 20 mg. bethanechol in 150 cc of
sodium chloride 0.3% with and without 20 mA. of pulsed current applied via
an electrode catheter through the saline. Cystometry simultaneously record
ed intravesical pressure changes. In phase 2, 45 patients with detrusor are
flexia were tested with electromotive administration of intravesical bethan
echol. In phase 3, 25 mg. bethanechol given orally once daily were prescrib
ed for 15 patients and voiding control was assessed after 6 weeks of therap
y.
Results: Neither bethanechol without current nor current through saline onl
y led to increased intravesical pressure. However, we noted a mean pressure
increase of 34 cm. water during the electromotive administration of bethan
echol in 24 of 26 patients with areflexia and neurological disease compared
to only 3 cm. water in 3 of 11 with a history of chronic bladder dilatatio
n. Oral bethanechol restored spontaneous voiding in 9 of 11 patients who ha
d had a positive response to the electromotive administration of bethanecho
l, whereas all 4 without a pressure increase during the electromotive admin
istration of bethanechol did not void spontaneously.
Conclusions: Electromotive administration of intravesical bethanechol ident
ifies patients with an atonic bladder and adequate residual detrusor muscle
function who are candidates for restorative measures, such as oral bethane
chol and intravesical electrostimulation. Those who do not respond to the e
lectromotive administration of bethanechol do not benefit from oral bethane
chol and are candidates for catheterization.